PRKAA1 and metabolic dysfunction-associated steatotic liver disease: This supports the hypothesis of a crucial role of AMPK as molecular node between the epidemic pathologies obesity, type 2 diabetes (T2D), and NAFLD [7,8,9,10,11,12,13,14].